Related Experiment Video
Updated: May 24, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
[Clinical analysis of 200 patients with primary gastric lymphoma]
Yuan Lv1, Xiao-Na Wang, Han Liang
1Department of Gastric Cancer, Tianjin Cancer Hospital, Tianjin, China.
Objective:
To study the clinical diagnosis, treatment and prognosis of primary gastric lymphoma (PGL).
Methods:
Clinical data of 200 patients with PGL who were treated at the Tianjin Cancer Hospital were retrospectively reviewed.
Results:
There were 110 males and 90 females. The age ranged between 19 and 80 (median, 54) years old. Symptoms or laboratory examinations were not specific. Before the treatment, 130 cases were diagnosed correctly, and the remaining 70 were misdiagnosed as gastric cancer (n=59), gastric ulcer (n=5) and chronic gastritis (n=6). Twenty-four cases received chemotherapy alone, 29 cases surgery alone, 132 cases underwent surgery plus chemotherapy, and 15 were not treated. The 200 cases all received follow-up ranging from 1 to 246 months (median, 26 months). The 1, 3, 5, and 10-year survival rates were 65.0%, 57.5%, 56.2%, and 55.0%. Univariate analysis and multivariate analysis showed that emaciation (P<0.01), tumor location (P<0.01), treatment modality (P<0.01), histological type (P<0.05), and tumor staging (P<0.05) were independent factors of survival in patients with PGL.
Conclusions:
The misdiagnosis of PGL is very frequent. The treatment of choice should be comprehensive therapy based on surgery.
